# DESCRIPTION

## FIELD OF INVENTION

## BACKGROUND

## SUMMARY OF THE INVENTION

## DETAILED DESCRIPTION OF THE INVENTION

### Prediction of In Vivo Toxicity

### Primary Mammalian Hepatocyte Cells

### Administering the Oligonucleotideâ€”Gymnotic Delivery (Gymnosis)

### Control Data/Reference Values

### (Determination of) Hepatotoxicity

### Parent Oligonucleotide

### Library of Variants

### Stereodefined Oligonucleotide Embodiments:

### Primary Hepatocytes Assay Example:

## Definitions

### Oligonucleotide

### Antisense Oligonucleotides (ASOs)

### Modified Internucleoside Linkages

### Modulation of Expression

### Modified Oligonucleotides

### RNase H Activity and Recruitment

### Efficacy

### Conjugate Moieties

### Stereodefined Oligonucleotides

## Immunotoxicity Biomarker Assay:

## EXAMPLES

### Example 1

### Example 2

### Example 3

### Example 4

### Example 5

### Example 6

### Example 7

### Example 8

### Example 9

